sulfinpyrazone 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
anti-inflammatory analgesics, phenylbutazone derivatives 2528 57-96-5

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • sulfinpyrazone
  • diphenylpyrazone
  • sulfinpyrazon
  • sulfoxyphenylpyrazolidine
  • sulphinpyrazone
  • sulfoxyphenylpyrazolidin
A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
  • Molecular weight: 404.48
  • Formula: C23H20N2O3S
  • CLOGP: 2.43
  • LIPINSKI: 0
  • HAC: 5
  • HDO: 0
  • TPSA: 57.69
  • ALOGS: -3.10
  • ROTB: 6
  • Status: OFM
    • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
0.30 g O

ADMET properties:

Approvals:

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

External reference:

Pharmaceutical products:

None

sulfinpyrazone